CN101851637B - Method for preparing transgenic animal for expressing multiple genes simultaneously - Google Patents
Method for preparing transgenic animal for expressing multiple genes simultaneously Download PDFInfo
- Publication number
- CN101851637B CN101851637B CN2010100343183A CN201010034318A CN101851637B CN 101851637 B CN101851637 B CN 101851637B CN 2010100343183 A CN2010100343183 A CN 2010100343183A CN 201010034318 A CN201010034318 A CN 201010034318A CN 101851637 B CN101851637 B CN 101851637B
- Authority
- CN
- China
- Prior art keywords
- sequence
- transgenic
- gene
- appa
- embryo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 50
- 241001465754 Metazoa Species 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 27
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 20
- 108010011619 6-Phytase Proteins 0.000 claims abstract description 10
- 239000002773 nucleotide Substances 0.000 claims description 21
- 125000003729 nucleotide group Chemical group 0.000 claims description 21
- 210000002257 embryonic structure Anatomy 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 17
- 241000282326 Felis catus Species 0.000 claims description 4
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 4
- 241000009328 Perro Species 0.000 claims description 4
- 238000013467 fragmentation Methods 0.000 claims description 2
- 238000006062 fragmentation reaction Methods 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 101150050411 appA gene Proteins 0.000 description 26
- 101100148259 Actinobacillus pleuropneumoniae apxIIA gene Proteins 0.000 description 22
- 230000003321 amplification Effects 0.000 description 19
- 238000003199 nucleic acid amplification method Methods 0.000 description 19
- 230000014509 gene expression Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 239000013612 plasmid Substances 0.000 description 14
- 239000012634 fragment Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000000246 agarose gel electrophoresis Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 101150009493 mxa gene Proteins 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000000520 microinjection Methods 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 101150107168 AMP gene Proteins 0.000 description 1
- 108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 1
- 101100364969 Dictyostelium discoideum scai gene Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 241001071864 Lethrinus laticaudis Species 0.000 description 1
- 101100364971 Mus musculus Scai gene Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 101100503668 Sus scrofa GAPDH gene Proteins 0.000 description 1
- 101001022035 Sus scrofa Glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 239000010828 animal waste Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/108—Swine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010100343183A CN101851637B (en) | 2010-01-15 | 2010-01-15 | Method for preparing transgenic animal for expressing multiple genes simultaneously |
PCT/CN2010/000943 WO2011085528A1 (en) | 2010-01-15 | 2010-06-24 | Method for preparing transgenic animals simultaneously expressing multiple genes |
US13/122,399 US8742085B2 (en) | 2010-01-15 | 2010-06-24 | Method for preparing a transgenic animal of simultaneous multiple-gene expression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010100343183A CN101851637B (en) | 2010-01-15 | 2010-01-15 | Method for preparing transgenic animal for expressing multiple genes simultaneously |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101851637A CN101851637A (en) | 2010-10-06 |
CN101851637B true CN101851637B (en) | 2011-12-14 |
Family
ID=42803315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010100343183A Active CN101851637B (en) | 2010-01-15 | 2010-01-15 | Method for preparing transgenic animal for expressing multiple genes simultaneously |
Country Status (3)
Country | Link |
---|---|
US (1) | US8742085B2 (en) |
CN (1) | CN101851637B (en) |
WO (1) | WO2011085528A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110846337A (en) * | 2019-11-26 | 2020-02-28 | 温氏食品集团股份有限公司 | Multifunctional fusion enzyme XABT gene, and construction method and application thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63500800A (en) * | 1985-07-31 | 1988-03-24 | スタエリ,ピ−タ− | Insertion of a gene encoding an interferon-induced protein into an animal |
JPH07246040A (en) * | 1993-07-06 | 1995-09-26 | Takeda Chem Ind Ltd | Germ stem cell having deactivated neurotrophin-3 gene and animal of manifestation incompetence of the same gene |
US7115795B1 (en) * | 1999-04-23 | 2006-10-03 | University Of Guelph | Transgenic animals expressing salivary proteins |
AU4095800A (en) * | 1999-04-23 | 2000-11-10 | University Of Guelph | Transgenic animals expressing salivary proteins |
ES2156579B1 (en) * | 2000-01-20 | 2002-01-16 | Univ Murcia | DEVICE AND METHOD FOR INTRODUCING AND / OR COLLECTING FLUIDS INSIDE THE UTERUS OF AN ANIMAL. |
MXPA03001281A (en) * | 2000-08-11 | 2003-06-30 | The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services | Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed. |
DK1616012T3 (en) * | 2003-04-24 | 2008-04-21 | San Raffaele Centro Fond | Lentiviral vectors bearing synthetic bidirectional promoters and their applications |
WO2006037052A2 (en) * | 2004-09-27 | 2006-04-06 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health | Modulating mxa expression |
WO2006063588A1 (en) * | 2004-12-13 | 2006-06-22 | Novozymes A/S | Polypeptides having acid phosphatase activity and polynucleotides encoding same |
CA2608481A1 (en) * | 2005-05-14 | 2006-11-23 | Fudan University | Piggybac as a tool for genetic manipulation and analysis in vertebrates |
CN101608189B (en) * | 2009-07-17 | 2011-01-05 | 中国农业科学院北京畜牧兽医研究所 | Eukaryotic expression carrier for expressing double genes |
-
2010
- 2010-01-15 CN CN2010100343183A patent/CN101851637B/en active Active
- 2010-06-24 US US13/122,399 patent/US8742085B2/en active Active
- 2010-06-24 WO PCT/CN2010/000943 patent/WO2011085528A1/en active Application Filing
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110846337A (en) * | 2019-11-26 | 2020-02-28 | 温氏食品集团股份有限公司 | Multifunctional fusion enzyme XABT gene, and construction method and application thereof |
CN110846337B (en) * | 2019-11-26 | 2023-02-28 | 温氏食品集团股份有限公司 | Multifunctional fusion enzyme XABT gene, construction method and application |
Also Published As
Publication number | Publication date |
---|---|
CN101851637A (en) | 2010-10-06 |
US20120233717A1 (en) | 2012-09-13 |
US8742085B2 (en) | 2014-06-03 |
WO2011085528A1 (en) | 2011-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101320489B1 (en) | Serum-free stable transfection and production of recombinant human proteins in human cell lines | |
KR101953237B1 (en) | Novel dna-binding proteins and uses thereof | |
KR101828828B1 (en) | Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof | |
EP3158073B1 (en) | Compositions and methods for making (s)-norcoclaurine and (s)-norlaudanosoline, and synthesis intermediates thereof | |
KR101921698B1 (en) | Recombinantly produced human factor VIII and IX | |
CN107501405B (en) | Autophagy inhibiting polypeptide | |
SG185920A1 (en) | Dac hyp compositions and methods | |
EP3405484A1 (en) | A method for producing insulin and insulin derivatives, and hybrid peptide used in this method | |
CN109021086B (en) | Antibacterial peptide cecropin A mutant and encoding gene, preparation method and application thereof | |
CN101851637B (en) | Method for preparing transgenic animal for expressing multiple genes simultaneously | |
CN113736763B (en) | Myrosinase Rmmr and application thereof in preparation of sulforaphane and sulforaphane | |
KR20120059222A (en) | Novel hybrid promoter and recombinant vector which includes the promoter | |
CN109134638B (en) | House dust mite allergen Der p 22 gene recombinant protein and application thereof | |
Acker et al. | Structure of the gene encoding the 14.5 kDa subunit of human RNA polymerase II | |
CN114395020B (en) | Application of GmRALF1 protein in promoting phosphorus element absorption of plants | |
EP3344651B1 (en) | A process for obtaining insulin with correctly formed disulfide bonds | |
CN101570760B (en) | Recombinant mouse beta-alexin 3 polypeptide, preparation and use thereof | |
CN109369794B (en) | Protein with function of regulating and controlling macrophage immune function activity | |
CN114207133A (en) | Compositions and methods for treating DBA using GATA1 gene therapy | |
CN112342245B (en) | CRISPR-Cas13d system for promoting suspension of CHO cells and recombinant CHO cells | |
US11401311B2 (en) | Recombinant activin A precursor protein | |
EP2240511A2 (en) | Compositions and methods for treating erectile dysfunction | |
CN107653244B (en) | Hemostatic protein and preparation method and application thereof | |
KR20100125171A (en) | Soluble myostatin prodomain recombination protein having myostatin inhibitory activity and its use | |
CN102153642B (en) | Application of protein with function of inhibiting growth of scar fibroblast |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Kui Inventor after: Ju Huiming Inventor after: Fan Junhua Inventor after: Bai Lijing Inventor after: Mou Yulian Inventor after: Yang Shulin Inventor after: Tang Zhonglin Inventor after: Cui Wentao Inventor after: Zhou Rong Inventor before: Li Kui Inventor before: Ju Huiming Inventor before: Fan Junhua Inventor before: Bai Lijing Inventor before: Mou Yulian Inventor before: Yang Shulin Inventor before: Tang Zhonglin Inventor before: Cui Wentao |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI KUI JU HUIMING FAN JUNHUA BAI LIJING MOU YULIAN YANG SHULIN TANG ZHONGLIN CUI WENTAO TO: LI KUI JU HUIMING FAN JUNHUA BAI LIJING MOU YULIAN YANG SHULIN TANG ZHONGLIN CUI WENTAO ZHOU RONG |